RT Book, Section A1 Rogers, Kelly C. A1 Spinler, Sarah A. A2 Chisholm-Burns, Marie A. A2 Schwinghammer, Terry L. A2 Malone, Patrick M. A2 Kolesar, Jill M. A2 Bookstaver, P. Brandon A2 Lee, Kelly C. SR Print(0) ID 1187007391 T1 Acute Coronary Syndromes T2 Pharmacotherapy Principles & Practice, 6e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781260460278 LK ppp.mhmedical.com/content.aspx?aid=1187007391 RD 2024/10/05 AB LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Define the role of atherosclerotic plaque, platelets, and the coagulation system in an acute coronary syndrome (ACS).List key electrocardiographic (ECG), biomarker, and clinical features identifying a patient with non–ST-segment elevation (NSTE)-ACS and ST-segment elevation myocardial infarction (STEMI).Devise an initial, early pharmacotherapy treatment and monitoring plan for a patient presenting with either NSTE-ACS or STEMI given patient-specific data.Devise an antithrombotic pharmacotherapy treatment and monitoring plan for a patient with NSTE-ACS or STEMI undergoing percutaneous coronary intervention (PCI) given patient-specific data.Devise an antithrombotic pharmacotherapy treatment and monitoring plan for a patient with NSTE-ACS or STEMI not undergoing PCI given patient-specific data.Develop a pharmacotherapy and risk factor modification treatment plan for secondary prevention of coronary heart disease (CHD) events in a patient following NSTE-ACS or STEMI.